title: Should the treatment of anal carcinoma be adapted in the elderly? A retrospective analysis of toxicities in a French center.
authors.forename: Berardino De
authors.initials: BD
authors.lastname: Bari
authors.forename: Tarik
authors.initials: T
authors.lastname: Chekrine
authors.forename: Ibrahim Shakir
authors.initials: IS
authors.lastname: Shakir
authors.forename: Jean Michel
authors.initials: JM
authors.lastname: Ardiet
authors.forename: Jean Pierre
authors.initials: JP
authors.lastname: Gerard
authors.forename: Olivier
authors.initials: O
authors.lastname: Chapet
authors.forename: Françoise
authors.initials: F
authors.lastname: Mornex
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001005:Anus Neoplasms / Q000628:therapy*; D001918:Brachytherapy / Q000009:adverse effects*; D002277:Carcinoma / Q000628:therapy*; D059248:Chemoradiotherapy / Q000009:adverse effects*; D019583:Dose Fractionation, Radiation; D005602:France; D006801:Humans; D018579:Patient Selection; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome